ArticleJournal of pharmaceutical and biomedical analysis2023

Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasma.

Melody F Myszkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.